PTEN contributes to profound PI3K/Akt signaling pathway deregulation in dystrophin-deficient dog muscle

American Journal of Pathology

Volumn 174, Issue 4, 2009, Pages 1459-1470

  Feron, Marie ^a   Guevel, Laetitia ^a,b   Rouger, Karl ^c   Dubreil, Laurence ^c   Arnaud, Marie Claire ^a   Ledevin, Mireille ^c   Megeney, Lynn A ^a   Cherel, Yan ^c   Sakanyan, Vehary ^a,d  

^a UNIVERSITÉ DE NANTES   (France)

^b OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^c INRA UMR 703   (France)

^d ProtNeteomix   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DYSTROPHIN; GLYCOGEN SYNTHASE KINASE 3BETA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; S6 KINASE; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; CYTOSOL; DEREGULATION; DOG; DUCHENNE MUSCULAR DYSTROPHY; ENZYMATIC ASSAY; IMMUNOHISTOCHEMISTRY; MUSCLE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; WESTERN BLOTTING; ANIMAL; ANIMAL MUSCULAR DYSTROPHY; CONFOCAL MICROSCOPY; HUMAN; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHOSPHORYLATION; PHYSIOLOGY; SIGNAL TRANSDUCTION; SKELETAL MUSCLE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; BLOTTING, WESTERN; DOGS; DYSTROPHIN; GLYCOGEN SYNTHASE KINASE 3; HUMANS; IMMUNOHISTOCHEMISTRY; MICROSCOPY, CONFOCAL; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, ANIMAL; MUSCULAR DYSTROPHY, DUCHENNE; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; PTEN PHOSPHOHYDROLASE; RIBOSOMAL PROTEIN S6 KINASES, 70-KDA; SIGNAL TRANSDUCTION;

EID: 65349105321     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2009.080460     Document Type: Article

References (54)

1. Monaco AP, Neve RL, Colletti-Feener C, Bertelson CJ, Kurnit DM, Kunkel LM: Isolation of candidate cDNAs for portions of the Duch-enne muscular dystrophy gene. Nature 1986, 323:646-650
2. Koenig M, Hoffman EP, Bertelson CJ, Monaco AP, Feener C, Kunkel LM: Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell 1987, 50:509-517
3. Hoffman EP, Brown RH Jr, Kunkel LM: Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 1987, 51:919-928
4. Campbell KP, Kahl SD: Association of dystrophin and an integral membrane glycoprotein. Nature 1989, 338:259-262
5. Ervasti JM, Ohlendieck K, Kahl SD, Gaver MG, Campbell KP: Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle. Nature 1990, 345:315-319
6. Yoshida M, Ozawa E: Glycoprotein complex anchoring dystrophin to sarcolemma. J Biochem (Tokyo) 1990, 108:748-752
7. Ibraghimov-Beskrovnaya O, Ervasti JM, Leveille CJ, Slaughter CA, Sernett SW, Campbell KP: Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix. Nature 1992, 355:696-702
8. Ohlendieck K, Campbell KP: Dystrophin-associated proteins are greatly reduced in skeletal muscle from mdx mice. J Cell Biol 1991, 115:1685-1694
9. Yang B, Jung D, Motto D, Meyer J, Koretzky G, Campbell KP: SH3 domain-mediated interaction of dystroglycan and Grb2. J Biol Chem 1995, 270:11711-11714
10. Brenman JE, Chao DS, Xia H, Aldape K, Bredt DS: Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy. Cell 1995, 82:743-752
11. Madhavan R, Massom LR, Jarrett HW: Calmodulin specifically binds three proteins of the dystrophin-glycoprotein complex. Biochem Bio- phys Res Commun 1992, 185:753-759
12. Cavaldesi M, Macchia G, Barca S, Defilippi P, Tarone G, Petrucci TC: Association of the dystroglycan complex isolated from bovine brain synaptosomes with proteins involved in signal transduction. J Neuro- chem 1999, 72:1648-1655
13. Crosbie RH, Yamada H, Venzke DP, Lisanti MP, Campbell KP: Caveolin-3 is not an integral component of the dystrophin glycoprotein complex. FEBS Lett 1998, 427:279-282
14. Song KS, Scherer PE, Tang Z, Okamoto T, Li S, Chafel M, Chu C, Kohtz DS, Lisanti MP: Expression of caveolin-3 in skeletal, cardiac, and smooth muscle cells. Caveolin-3 is a component of the sarco- lemma and co-fractionates with dystrophin and dystrophin-associ-ated glycoproteins. J Biol Chem 1996, 271:15160-15165
15. Sotgia F, Lee JK, Das K, Bedford M, Petrucci TC, Macioce P, Sargiacomo M, Bricarelli FD, Minetti C, Sudol M, Lisanti MP: Caveo- lin-3 directly interacts with the C-terminal tail of beta-dystroglycan. Identification of a central WW-like domain within caveolin family members. J Biol Chem 2000, 275:38048-38058
16. Bulfield G, Siller WG, Wight PAG, Moore KJ: X chromosome-linked muscular dystrophy (mdx) in the mouse. Proc Natl Acad Sci USA 1984, 81:1189-1192
17. Kumar A, Khandelwal N, Malya R, Reid MB, Boriek AM: Loss of dystrophin causes aberrant mechanotransduction in skeletal muscle fibers. FASEB J 2004, 18:102-113
18. Lang JM, Esser KA, Dupont-Versteegden EE: Altered activity of signaling pathways in diaphragm and tibialis anterior muscle of dystrophic mice. Exp Biol Med (Maywood) 2004, 229:503-511
19. Kolodziejczyk SM, Walsh GS, Balazsi K, Seale P, Sandoz J, Hierlihy AM, Rudnicki MA, Chamberlain JS, Miller FD, Megeney LA: Activation of JNK1 contributes to dystrophic muscle pathogenesis. Curr Biol 2001, 11:1278-1282
20. Nakamura A, Yoshida K, Ueda H, Takeda S, Ikeda S: Up-regulation of mitogen activated protein kinases in mdx skeletal muscle following chronic treadmill exercise. Biochim Biophys Acta 2005, 1740:326-331
21. St-Pierre SJ, Chakkalakal JV, Kolodziejczyk SM, Knudson JC, Jasmin BJ, MegeneyLA: Glucocorticoid treatment alleviates dystrophic myo-fiber pathology by activation of the calcineurin/NF-AT pathway. FASEB J 2004, 18:1937-1939
22. Dogra C, Changotra H, Wergedal JE, Kumar A: Regulation of phos-phatidylinositol 3-kinase (PI3K)/Akt and nuclear factor-kappa B signaling pathways in dystrophin-deficient skeletal muscle in response to mechanical stretch. J Cell Physiol 2006, 208:575-585
23. Peter AK, Crosbie RH: Hypertrophic response of Duchenne and limb-girdle muscular dystrophies is associated with activation of Akt pathway. Exp Cell Res 2006, 312:2580-2591
24. Carnwath JW, Shotton DM: Muscular dystrophy in the mdx mouse: histopathology of the soleus and extensor digitorum longus muscles. J Neurol Sci 1987, 80:39-54
25. Coulton GR, Morgan JE, Partridge TA, Sloper JC: The mdx mouse skeletal muscle myopathy: I. A histological, morphometric and biochemical investigation. Neuropathol Appl Neurobiol 1988, 14:53-70
26. Torres LF, Duchen LW: The mutant mdx: inherited myopathy in the mouse. Morphological studies of nerves, muscles and end-plates. Brain 1987, 110 (Pt 2):269-299
27. Cooper BJ, Winand NJ, Stedman H, Valentine BA, Hoffman EP, Kunkel LM, Scott MO, Fischbeck KH, Kornegay JN, Avery RJ, Williams JR, Schmickel RD, Sylvester JE: The homologue of the Duchenne locus is defective in X-linked muscular dystrophy of dogs. Nature 1988, 334:154-156
28. Valentine BA, Cooper BJ, de Lahunta A, O'Quinn R, Blue JT: Canine X-linked muscular dystrophy. An animal model of Duchenne muscular dystrophy: clinical studies. J Neurol Sci 1988, 88:69-81
29. Sharp NJ, Kornegay JN, Van Camp SD, Herbstreith MH, Secore SL, Kettle S, Hung WY, Constantinou CD, Dykstra MJ, Roses AD, Bartlett RJ: An error in dystrophin mRNA processing in golden retriever muscular dystrophy, an animal homologue of Duchenne muscular dystrophy. Genomics 1992, 13:115-121
30. Bodine SC, Stitt TN, Gonzalez M, Kline WO, Stover GL, Bauerlein R, Zlotchenko E, Scrimgeour A, Lawrence JC, Glass DJ, Yancopoulos GD: Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat Cell Biol 2001, 3:1014-1019
31. Glass DJ: Skeletal muscle hypertrophy and atrophy signaling pathways. Int J Biochem Cell Biol 2005, 37:1974-1984
32. Rommel C, Bodine SC, Clarke BA, Rossman R, Nunez L, Stitt TN, Yancopoulos GD, Glass DJ: Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways. Nat Cell Biol 2001, 3:1009-1013
33. Vyas DR, Spangenburg EE, Abraha TW, Childs TE, Booth FW: GSK-3beta negatively regulates skeletal myotube hypertrophy. Am J Physiol Cell Physiol 2002, 283:C545-C551
34. Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA: Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 1995, 378:785-789
35. Chung J, Kuo CJ, Crabtree GR, Blenis J: Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70 kd S6 protein kinases. Cell 1992, 69:1227-1236
36. Inoki K, Li Y, Zhu T, Wu J, Guan KL: TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. Nat Cell Biol 2002, 4:648-657
37. Inoki K, Ouyang H, Li Y, Guan KL: Signaling by target of rapamycin proteins in cell growth control. Microbiol Mol Biol Rev 2005, 69: 79-100
38. Price DJ, Grove JR, Calvo V, Avruch J, Bierer BE: Rapamycin-in-duced inhibition of the 70-kilodalton S6 protein kinase. Science 1992, 257:973-977
39. Whitman M, Downes CP, Keeler M, Keller T, Cantley L: Type I phos-phatidylinositol kinase makes a novel inositol phospholipid, phospha-tidylinositol-3-phosphate. Nature 1988, 332:644-646
40. Alessi DR, James SR, Downes CP, Holmes AB, Gaffney PR, Reese CB, Cohen P: Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase B alpha. Curr Biol 1997, 7:261-269
41. Millward TA, Zolnierowicz S, Hemmings BA: Regulation of protein kinase cascades by protein phosphatase 2A. Trends Biochem Sci 1999, 24:186-191
42. Maehama T, Dixon JE: The tumor suppressor. PTEN/MMAC1, de- phosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem 1998, 273:13375-13378
43. Lai KM, Gonzalez M, Poueymirou WT, Kline WO, Na E, Zlotchenko E, Stitt TN, Economides AN, Yancopoulos GD, Glass DJ: Conditional activation of akt in adult skeletal muscle induces rapid hypertrophy. Mol Cell Biol 2004, 24:9295-9304
44. Vazquez F, Devreotes P: Regulation of PTEN function as a PIP3 gatekeeper through membrane interaction. Cell Cycle 2006, 5:1523-1527
45. Vazquez F, Matsuoka S, Sellers WR, Yanagida T, Ueda M, Devreotes PN: Tumor suppressor PTEN acts through dynamic interaction with the plasma membrane. Proc Natl Acad Sci USA 2006, 103: 3633-3638
46. Caselli A, Mazzinghi B, Camici G, Manao G, Ramponi G: Some protein tyrosine phosphatases target in part to lipid rafts and interact with caveolin-1. Biochem Biophys Res Commun 2002, 296:692-697
47. Bonilla E, Fischbeck K, Schotland DL: Freeze-fracture studies of muscle caveolae in human muscular dystrophy. Am J Pathol 1981, 104:167-173
48. Galbiati F, Razani B, Lisanti MP: Caveolae and caveolin-3 in muscular dystrophy. Trends Mol Med 2001, 7:435-441
49. Repetto S, Bado M, Broda P, Lucania G, Masetti E, Sotgia F, Carbone I, Pavan A, Bonilla E, Cordone G, Lisanti MP, Minetti C: Increased number of caveolae and caveolin-3 overexpression in Duchenne muscular dystrophy. Biochem Biophys Res Commun 1999, 261:547-550
50. Yin Y, Shen WH: PTEN: a new guardian of the genome. Oncogene 2008, 27:5443-5453
51. Liaw D, Marsh DJ, Li J, Dahia PL, Wang SI, Zheng Z, Bose S, Call KM, Tsou HC, Peacocke M, Eng C, Parsons R: Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet 1997, 16:64-67
52. Ishihara H, Sasaoka T, Kagawa S, Murakami S, Fukui K, Kawagishi Y, Yamazaki K, Sato A, Iwata M, Urakaze M, Ishiki M, Wada T, Yaguchi S, Tsuneki H, Kimura I, Kobayashi M: Association of the polymorphisms in the 5'-untranslated region of PTEN gene with type 2 diabetes in a Japanese population. FEBS Lett 2003, 554:450-454
53. McNally EM, de Sa Moreira E, Duggan DJ, Bonnemann CG, Lisanti MP, Lidov HG, Vainzof M, Passos-Bueno MR, Hoffman EP, Zatz M, Kunkel LM: Caveolin-3 in muscular dystrophy. Hum Mol Genet 1998, 7:871-877
54. Minetti C, Sotgia F, Bruno C, Scartezzini P, Broda P, Bado M, Masetti E, Mazzocco M, Egeo A, Donati MA, Volonte D, Galbiati F, Cordone G, Bricarelli FD, Lisanti MP, Zara F: Mutations in the caveolin-3 gene cause autosomal dominant limb-girdle muscular dystrophy. Nat Genet 1998, 18:365-368